British pharmaceutical firm GlaxoSmithKline is planning to cut the prices of many of its leading medicines in emerging markets, CEO Andrew Witty said in an interview with the Financial Times.
You are here: Home / Women's Health / Menstrual Cycle / Menstrual Suppression / GSK to cut prices in emerging markets – CEO
GSK to cut prices in emerging markets – CEO
LONDON, June 12 (Reuters)
“Making sure the price-volume equation is right is a key piece of the strategy,” Witty was quoted as saying in the paper’s Friday edition.